MRC1 and gastric adenocarcinoma: Specifically, mutations in MMR genes (MLH1, MSH2, MSH6, and PMS2) lead to the loss of DDR activity and contribute to hypermutation in colorectal cancer and stomach adenocarcinoma [23,24].